Current NHS consultant posts held
Consultant Haematologist
Department of Haematology
UNIVERSITY COLLEGE LONDON HOSPITAL
& LONDON NORTH WEST UNIVERSITY HEALTHCARE NHS Trusts
Research interests
Multiple Myeloma
Multiple Myeloma Spinal Disease
Multiple Myeloma and Haemopoietic Stem Cell Stem Cell Transplantation
Lymphomas
Lymphomas and Haemopoietic Stem Cell Transplantation
Haemopoietic Stem Cell Transplantation for Multiple Sclerosis
Waldenstrom's Macriglobulinemia
Quality of life for haematological malignancies
Personal interests
Allogeneic transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: LWP/EBMT. J Clin Oncol. 2009 Aug 20;27(24):3951-8.
Autologous transplantation in WM. The LWP/EBMT experience. J Clin Oncol. 2010 May 1;28(13):2227-32.
Allogeneic transplantation in patients with WM: report from the LWP/EBMT J Clin Oncol. 2010 Nov 20;28(33):4926-34.
Treatment recommendations for patients with WM and related disorders: IWWM-7 consensus. Blood. 2014 Aug 28;124(9):1404-11.
Awards received
London North West University Healthcare NHS Trust - SAutologous transplantation in angioimmunoblastic lymphoma. LWP/EBMT. J Clin Oncol. 2008 Jan 10;26(2):218-24.
Excellence award 2013
(Additional) Languages spoken
Publications
Optimizing the management of patients with spinal myeloma disease. Br J Haematol. 2015
Treatment recommendations from the Eight International Workshop on WM. Blood. 2016
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors:IMWG study. Leukemia. 2017
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Qual Life Res. 2018
Stem Cell Transplantation in WM. Hematol Oncol Clin North Am. 2018
The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG). Blood Cancer J. 2019 Feb 26;9(3):27.
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party. Biol Blood Marrow Transplant. 2019 Jan;25(1):86-93.
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT. Bone Marrow Transplant. 2020 May 15.
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood Cancer J. 2020 Oct
Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2020 Feb;55(2)
Bone Working Group of the International Myeloma Working, Group et al, Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Lancet Oncol. 2021 Mar;22(3)
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma; 2021; Radiol Imaging Cancer; Vol 3 (5);
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of healthrelated quality of life for patients with CLL leukaemia. 2022; Br J Haematol. Vol 197,
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: The Lancet Healthy Longevity, Volume 3 Issue 9, Sept 2022;
Courses offered to GPs
The European landscape on allogeneic transplantation in CLL: a perspective from the CMWP/EBMT; Bone Marrow Transplant 2023. International validation of two EORTC questionnaires for assessment of health-related QOL for high- and low- grade non-Hodgkin lymphoma (QLQ-NHL-HG29) (QLQ-NHL-LG20) EORTC QOLG Cancer. 2023. Use of the EORTC myeloma module (EORTC QLQ-MY20) Blood Cancer J. 2023. International validation of a health-related QOLQ for Hodgkin Lymphoma: the EORTC QLQ-HL27 Blood Adv2023.
